BioCentury
ARTICLE | Company News

Myriad Genetics, University of Wales deal

April 19, 2004 7:00 AM UTC

The university's Institute of Medical Genetics granted MYGN exclusive U.S. rights to detect mutations in Mut Y Homolog (MYH), a DNA repair gene implicated in colon cancer. MYGN will add MYH detection ...